MicardisPlus ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

micardisplus

boehringer ingelheim international gmbh - telmisartan, hydrochlorothiazide - hypertensjon - agenter som virker på renin-angiotensinsystemet - behandling av essensiell hypertensjon. micardisplus fast dose kombinasjon (40 mg telmisartan / 12. 5 mg hydroklortiazid, 80 mg telmisartan / 12. 5 mg hydroklortiazid) er indisert hos pasienter hvor blodtrykket ikke er tilstrekkelig kontrollert på telmisartan alene. micardisplus fast dose kombinasjon (80 mg telmisartan / 25 mg hydroklortiazid) er indisert hos pasienter hvor blodtrykket ikke er tilstrekkelig kontrollert på micardisplus (80 mg telmisartan / 12. 5 mg hydroklortiazid) eller pasienter som tidligere har blitt stabilisert seg på telmisartan og hydroklortiazid gitt separat.

Tecartus ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Micardis ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

micardis

boehringer ingelheim international gmbh - telmisartan - hypertensjon - angiotensin ii antagonister, vanlig - hypertensiontreatment av essensiell hypertensjon hos voksne. kretsløpssystem preventionreduction av hjerte-sykdom hos pasienter med manifest atherothrombotic hjerte-og karsykdommer (history of coronary hjertesykdommer, hjerneslag, eller perifer arteriell sykdom) eller;type-2 diabetes mellitus med dokumentert mål-organskade.

Cardizem Retard 90 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem retard 90 mg

pfizer as - diltiazemhydroklorid - depottablett - 90 mg

Cardizem Retard 120 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem retard 120 mg

pfizer as - diltiazemhydroklorid - depottablett - 120 mg

Cardizem Retard 180 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem retard 180 mg

pfizer as - diltiazemhydroklorid - depottablett - 180 mg

Cardizem Uno 180 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem uno 180 mg

pfizer as - diltiazemhydroklorid - depottablett - 180 mg

Cardizem Uno 240 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem uno 240 mg

pfizer as - diltiazemhydroklorid - depottablett - 240 mg

Cardizem Uno 300 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

cardizem uno 300 mg

pfizer as - diltiazemhydroklorid - depottablett - 300 mg

MicardisPlus 80 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

micardisplus 80 mg / 12.5 mg

2care4 aps - telmisartan / hydroklortiazid - tablett - 80 mg / 12.5 mg